-
HepaPuff, an innovative handheld heparin nebulizer to prevent infection with...
HepaPuff, an innovative handheld heparin nebulizer to prevent infection with SARS-CoV-2 and new emerging respiratory viruses. -
BCG vaccination to minimise COVID-19 disease severity and duration
BCG vaccination to minimise COVID-19 disease severity and duration -
Kansen in Crisis: Hoe geven scholen vorm aan educatief partnerschap?
Kansen in Crisis: Hoe geven scholen vorm aan educatief partnerschap?; Chances in Crisis: How do schools shape school-family partnerships? -
The impact of COVID-19 on children and adolescents with Autism Spectrum...
The impact of COVID-19 on children and adolescents with Autism Spectrum Disorder (ASD) and their families; Impact van COVID-19 op kinderen en jongeren met autismespectrum... -
The impact of COVID-19 on illiterate people and people with a mild...
The impact of COVID-19 on illiterate people and people with a mild intellectual disabilities: preventative measures, (mental) health and support needs. -
Providing context to excess mortality through changes in healthcare use...
Providing context to excess mortality through changes in healthcare use during the COVID-19 pandemic -
A double-blind, placebo-controlled randomized clinical trial with valsartan...
A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2... -
Ethiek van e-Health tijdens de coronacrisis en daarna: lessen uit de pandemie
Ethiek van e-Health tijdens de coronacrisis en daarna: lessen uit de pandemie -
A Phase I-II study of virus neutralizing antibodies against SARS-CoV-2. A...
A Phase I-II study of virus neutralizing antibodies against SARS-CoV-2. A focus on convalescent plasma and hyperimmune anti-SARS-CoV-2 immunoglobulines -
Safety and efficacy of SARS-CoV-2 antibodies
Safety and efficacy of SARS-CoV-2 antibodies -
Convalescent plasma as a treatment for high-risk outpatients administered...
Convalescent plasma as a treatment for high-risk outpatients administered within 7 days after COVID-19 disease onset (CoV-Early) -
EQUalS: Mathematical modelling to inform an EQUitable and effective response...
EQUalS: Mathematical modelling to inform an EQUitable and effective response to epidemicS -
EXCEPTIUS : Exceptional powers in time of Sars -CoV-2
EXCEPTIUS : Exceptional powers in time of Sars -CoV-2 -
COVID-NL cohort LUMC
Clinical data of LUMC COVID-NL cohort -
Towards Evidence-based Social Distancing Policy: Tracking Behavioral...
Towards Evidence-based Social Distancing Policy: Tracking Behavioral Responses to Pandemic Mitigation Measures and Implementation Strategies -
Healthcare utilization in primary care during the corona pandemic: a...
Healthcare utilization in primary care during the corona pandemic: a nation-wide population-based study from a patient and healthcare provider perspective -
Vulnerable in Amsterdam: The organisation and effects of support to...
Vulnerable in Amsterdam: The organisation and effects of support to vulnerable groups during and after the corona-crisis -
CoviChron: Covid-19 and Chronic illness interactions in transmission dynamics
CoviChron: Covid-19 and Chronic illness interactions in transmission dynamics -
COVID-NL cohort AUMC
Clinical data of AUMC COVID-NL cohort -
Blood vessels-on-chip to understand and target COVID-19 intravascular coagulation
Blood vessels-on-chip to understand and target COVID-19 intravascular coagulation